Bio-Rad Laboratories (BIO-B) Operating Income Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bio-Rad Laboratories | - | - | 309.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.50% |
| Dec 31, 2025 | -21.43% |
| Sep 30, 2025 | -9.84% |
| Jun 30, 2025 | 8.30% |
| Mar 31, 2025 | -20.45% |
| Dec 31, 2024 | -0.31% |
| Sep 30, 2024 | 2.34% |
| Jun 30, 2024 | 12.47% |
| Mar 31, 2024 | -4.66% |
| Dec 31, 2023 | 19.33% |
| Sep 30, 2023 | 20.18% |
| Jun 30, 2023 | 15.40% |
| Mar 31, 2023 | 7.24% |
| Dec 31, 2022 | 20.92% |
| Sep 30, 2022 | 19.55% |
| Jun 30, 2022 | 136.67% |
| Mar 31, 2022 | 41.07% |
| Dec 31, 2021 | 43.95% |
| Sep 30, 2021 | 47.19% |
| Jun 30, 2021 | 35.92% |
| Mar 31, 2021 | 37.94% |
| Dec 31, 2020 | 25.55% |
| Sep 30, 2020 | 27.39% |
| Jun 30, 2020 | 5.18% |
| Mar 31, 2020 | 16.71% |
| Dec 31, 2019 | 3.20% |
| Sep 30, 2019 | 11.57% |
| Jun 30, 2019 | 4.30% |
| Mar 31, 2019 | 22.56% |
| Dec 31, 2018 | -44.68% |
| Sep 30, 2018 | 4.54% |
| Jun 30, 2018 | -3.72% |
| Mar 31, 2018 | 4.42% |
| Dec 31, 2017 | -7.32% |
| Sep 30, 2017 | -10.05% |
| Jun 30, 2017 | -15.14% |
| Mar 31, 2017 | -13.58% |
| Dec 31, 2016 | -18.06% |
| Sep 30, 2016 | -21.03% |
| Jun 30, 2016 | -16.97% |
| Mar 31, 2016 | -21.35% |
| Dec 31, 2015 | -5.22% |
| Sep 30, 2015 | -15.27% |
| Jun 30, 2015 | -10.02% |
| Mar 31, 2015 | -11.49% |
| Dec 31, 2014 | -2.12% |
| Sep 30, 2014 | -13.18% |
| Jun 30, 2014 | -3.95% |